503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-3.56%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-11.85%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-2.59%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
1.00%
Similar margin change to CRWV's 1.30%. Walter Schloss would investigate industry pricing power.
4.71%
R&D change of 4.71% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.13%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
0.62%
Total costs growth less than half of CRWV's 18.28%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-11.84%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-10.64%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-4.82%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-10.45%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-7.15%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-34.62%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-12.78%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-9.56%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-12.92%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-12.71%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-9.49%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
7.69%
EPS growth below 50% of CRWV's 23.08%. Michael Burry would check for structural issues.
7.69%
Diluted EPS growth below 50% of CRWV's 23.08%. Michael Burry would check for structural issues.
-20.59%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-20.59%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.